Table 1.
Stages of advancement of diabetic retinopathy in the experimental group with reference to type of diabetes.
| Experimental Group n (%) | p | |||
|---|---|---|---|---|
| Total | DM1 | DM2 | ||
| DR | 308 (25.48) | 102 (32.58) | 206 (23.04) | 0.001 |
| • NPDR | 230 (19.02) | 77 (24.44) | 153 (17.11) | 0.001 |
| • PDR | 14 (1.16) | 5 (1.59) | 9 (1.01) | ns |
| • DME | 60 (4.96) | 17 (5.40) | 43 (4.81) | 0.002 |
| • PDR and DME | 4 (0.33) | 3 (0.95) | 1 (0.11) | ns |
| Without DR | 901 (74.52) | 213 (67.62) | 688 (76.96) | 0.001 |
DM1: type 1 diabetes mellitus; DM2: type 2 diabetes mellitus; DR: diabetic retinopathy; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy; DME: diabetic macular edema, ns: not significant.